Elutia Inc - Class A

Research Elutia Inc - Class A (ELUT) on Bullrun: market cap USD 42.29M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerELUT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 42.29M
• Financial periodFY2025
• RevenueUSD 12.29M
• Revenue growth-15.0%
• Net incomeUSD 53.38M
• Free cash flow-USD 46.69M
• Gross margin53.7%

Valuation Snapshot

latest market cap is USD 42.29M.

About Elutia Inc - Class A

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction.

Frequently asked questions

What is Elutia Inc - Class A's market cap?

Elutia Inc - Class A's market capitalization is USD 42.29M.

What does Elutia Inc - Class A do?

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular.